Investor Stock List
Ranked #2,114 of 8,699 institutional investors

Cormorant Asset Management, LP

Boston, MA

$1.18B
US stock portfolio at live prices · today −$19.8M (−1.65%)
Live prices, last trade 10:50 AM ET
Value at quarter end (Q3 2026)
$1.49B
Change from Q2 2026
−$462.1M (−23.68%)
Positions
52 · 12 new, 1 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$76.1M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
PRAX 13.0%PBLS 10.9%EWTX 6.43%ERAS 5.78%RAPP 4.91%
StockSharesValue, live% of portfoliovs Q2 2026
PRAX Praxis Precision Medicines, Inc.500,000$153M13.0%Reduced −22%
PBLS Parabilis Medicines, Inc.4,615,612$128M10.9%Unchanged
EWTX Edgewise Therapeutics, Inc.1,860,000$75.7M6.43%Reduced −26%
ERAS Erasca, Inc.5,000,000$68.0M5.78%Reduced −17%
RAPP Rapport Therapeutics, Inc.2,457,521$57.8M4.91%Reduced −8%
BLSM BlossomHill Therapeutics, Inc.3,614,034$53.1M4.51%New
DNTH Dianthus Therapeutics, Inc.500,000$41.8M3.55%Reduced −33%
ORKA Oruka Therapeutics, Inc.400,000$38.0M3.23%Reduced −25%
ANL Adlai Nortye Group Ltd.3,978,229$34.8M2.96%Unchanged
BBOT BridgeBio Oncology Therapeutics, Inc.17,878,594$32.4M2.75%Unchanged
MLTX MoonLake Immunotherapeutics2,855,433$31.4M2.67%Reduced −11%
ETRA Electra Therapeutics, Inc.3,365,533$31.2M2.65%New
ABVX ABIVAX Société Anonyme425,000$28.9M2.45%Reduced −37%
ATTO Attovia Therapeutics, Inc.1,788,815$27.0M2.29%New
LTGO Latigo Biotherapeutics, Inc.1,815,740$23.0M1.96%New
IRD Opus Genetics, Inc.5,500,000$21.6M1.84%New
MBX MBX Biosciences, Inc.375,000$19.5M1.66%Reduced −32%
CLYM Climb Bio Inc2,106,000$19.4M1.65%Unchanged
BBIO BridgeBio Pharma, Inc.250,000$19.3M1.64%Reduced −55%
DRUG Bright Minds Biosciences Inc.800,000$16.8M1.43%Reduced −11%
TNGX Tango Therapeutics, Inc.700,000$15.7M1.33%Reduced −46%
AGMB AgomAb Therapeutics NV2,465,348$13.7M1.16%Unchanged
FRNM Freenome, Inc.1,431,032$13.5M1.15%New
ADRX ADARx Pharmaceuticals, Inc.962,898$13.5M1.15%New
OLMA Olema Oncology, Inc.1,750,000$12.5M1.07%Reduced −19%
SYRE Spyre Therapeutics, Inc.125,000$12.0M1.02%Reduced −44%
BIOA BioAge Labs, Inc.2,240,605$10.1M0.86%Reduced −6%
FTH Faeth Therapeutics, Inc.1,028,242$8.8M0.75%Added +236%
ALMS Alumis Inc.2,075,000$8.7M0.74%Reduced −37%
DFTX Definium Therapeutics, Inc.275,000$8.0M0.68%Reduced −31%
AMLX Amylyx Pharmaceuticals, Inc.300,000$7.8M0.66%Added +50%
ACRS Aclaris Therapeutics, Inc.1,750,000$6.1M0.52%New
CRBP Corbus Pharmaceuticals Holdings, Inc.2,344,971$5.2M0.44%Unchanged
JBIO Jade Biosciences, Inc.300,000$4.6M0.39%New
KLRA Kailera Therapeutics, Inc.400,000$4.6M0.39%Reduced −27%
CABA Cabaletta Bio, Inc.4,500,000$4.5M0.38%Reduced −10%
TARS Tarsus Pharmaceuticals, Inc.50,000$3.8M0.32%Reduced −50%
INBX Inhibrx Biosciences, Inc.50,000$3.7M0.31%New
ELVN Enliven Therapeutics, Inc.75,000$3.5M0.30%Reduced −50%
INSM Insmed Incorporated20,000$2.9M0.25%Reduced −73%
IBIO iBio, Inc.3,570,000$2.9M0.25%Unchanged
CUE Cue Biopharma, Inc.625,285$2.7M0.23%New
BOLD Boundless Bio, Inc.940,000$2.2M0.18%Reduced −6%
ODTX Odyssey Therapeutics, Inc.125,000$2.2M0.18%Reduced −29%
EYPT EyePoint, Inc.5,750,000$1.5M0.12%Reduced −18%
BRVE Braveheart Bio, Inc.70,000$1.4M0.12%New
ARQT Arcutis Biotherapeutics, Inc.50,000$1.3M0.11%Reduced −71%
PCVX Vaxcyte, Inc.15,000$863K<0.1%Reduced −70%
COGT Cogent Biosciences, Inc.30,000$817K<0.1%Reduced −70%
ARWR Arrowhead Pharmaceuticals, Inc.15,000$640K<0.1%Reduced −70%
GPCR Structure Therapeutics Inc.30,000$498K<0.1%Reduced −60%
IRLA IRulya Therapeutics Inc.5,498$222K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
ALT Altimmune, Inc.1,250,000$1.7M